[Complement activation and biological activities].
D000706:Anaphylatoxins / Q000494:pharmacology; D000818:Animals; D000936:Antigen-Antibody Complex; D002462:Cell Membrane / Q000648:ultrastructure; D002463:Cell Membrane Permeability; D003172:Complement C1 / Q000378:metabolism; D003175:Complement C2 / Q000378:metabolism; D003176:Complement C3 / Q000378:metabolism; D003181:Complement C4 / Q000378:metabolism; D003182:Complement C5 / Q000378:metabolism; D003183:Complement C6 / Q000378:metabolism; D003184:Complement C7 / Q000378:metabolism; D003185:Complement C8 / Q000378:metabolism; D003186:Complement C9 / Q000378:metabolism; D003165:Complement System Proteins / Q000378:metabolism*; D006168:Guinea Pigs; D006801:Humans; D007104:Immune Adherence Reaction; D009119:Muscle Contraction / Q000187:drug effects; D010323:Passive Cutaneous Anaphylaxis; D010587:Phagocytosis; D010740:Phospholipases / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D011414:Properdin / Q000378:metabolism; D011817:Rabbits
D000706:Anaphylatoxins; D000936:Antigen-Antibody Complex; D003172:Complement C1; D003175:Complement C2; D003176:Complement C3; D003181:Complement C4; D003182:Complement C5; D003183:Complement C6; D003184:Complement C7; D003185:Complement C8; D003186:Complement C9; D010743:Phospholipids; D011414:Properdin; D003165:Complement System Proteins; D010740:Phospholipases